In Vitro Effects of a Small-Molecule Antagonist of the Tcf/ß-Catenin Complex on Endometrial and Endometriotic Cells of Patients with Endometriosis

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Matsuzaki, Sachiko ^a,b,c   Darcha, Claude ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE GENITAL SYSTEM; BETA CATENIN; CGP 049090; CYCLIN D1; GELATINASE B; MESSENGER RNA; PKF 115 584; SMALL INTERFERING RNA; SURVIVIN; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; CTNNB1 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; PERYLENE; PKF115-584; WNT PROTEIN;

ADULT; ARTICLE; CELL COUNT; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; GENE TARGETING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PROTEIN EXPRESSION; STROMA CELL; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CASE CONTROL STUDY; CELL CULTURE; CELL MOTION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MENSTRUATION; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ADULT; BETA CATENIN; CASE-CONTROL STUDIES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOMETRIOSIS; ENDOMETRIUM; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MATRIX METALLOPROTEINASE 9; MENSTRUATION; PERYLENE; SIGNAL TRANSDUCTION; STROMAL CELLS; TCF TRANSCRIPTION FACTORS; WNT PROTEINS;

EID: 84876581873     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061690     Document Type: Article

References (38)

1. Giudice LC, Kao LC, (2004) Endometriosis. Lancet 364: 1789-1799.
2. Matsuzaki S, Darcha C, Maleysson E, Canis M, Mage G, (2010) Impaired down-regulation of E-cadherin and beta-catenin protein expression in endometrial epithelial cells in the mid-secretory endometrium of infertile patients with endometriosis. J Clin Endocrinol Metab 95: 3437-3445.
3. Matsuzaki S, Darcha C, (2012) Epithelial to mesenchymal transition-like and mesenchymal to epithelial transition-like processes might be involved in the pathogenesis of pelvic endometriosis. Hum Reprod 27: 712-721.
4. Klaus A, Birchmeier W, (2008) Wnt signalling and its impact on development and cancer. Nat Rev Cancer 8: 387-398.
5. Clevers H, (2006) Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
6. Grigoryan T, Wend P, Klaus A, Birchmeier W, (2008) Deciphering the function of canonical Wnt signals in development and disease: Conditional loss- and gain-of-function mutations of beta-catenin in mice. Genes Dev 22: 2308-2341.
7. Wend P, Holland JD, Ziebold U, Birchmeier W, (2010) Wnt signaling in stem and cancer stem cells. Semin Cell Dev Biol 21: 855-863.
8. Gonsalves FC, Klein K, Carson BB, Katz S, Ekas LA, et al. (2011) An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway. Proc Natl Acad Sci USA 108: 5954-5963.
9. Lepourcelet M, Chen YN, France DS, Wang H, Crews P, et al. (2004) Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell 5: 91-102.
10. Ewan K, Pajak B, Stubbs M, Todd H, Barbeau O, et al. (2010) A useful approach to identify novel small-molecule inhibitors of Wnt-dependent transcription. Cancer Res 70: 5963-5973.
11. Arkin MR, Whitty A, (2009) The road less traveled: Modulating signal transduction enzymes by inhibiting their protein-protein interactions. Curr Opin Chem Biol 13: 284-290.
12. Trosset JY, Dalvit C, Knapp S, Fasolini M, Veronesi M, et al. (2006) Inhibition of protein-protein interactions: The discovery of druglike beta-catenin inhibitors by combining virtual and biophysical screening. Proteins 64: 60-67.
13. Mosimann C, Hausmann G, Basler K, (2009) Beta-catenin hits chromatin: Regulation of Wnt target gene activation. Nat Rev Mol Cell Biol 10: 276-286.
14. Watanabe K, Dai X, (2011) Winning WNT: race to Wnt signaling inhibitors. Proc Natl Acad Sci U S A 108: 5929-5930.
15. Noyes RW, Hertig AT, Rock J, (1995) Dating the endometrial biopsy. Fertil Steril 1: 3-5.
16. Canis M, Mage G, Wattiez A, Pouly JL, Bruhat MA, (2003) The ovarian endometrioma: why is it so poorly managed? Laparoscopic treatment of large ovarian endometrioma: why such a long learning curve? Hum Reprod 2: 5-7.
17. Sugawara J, Fukaya T, Murakami T, Yoshida H, Yajima A, (1997) Hepatocyte growth factor stimulated proliferation, migration, and lumen formation of human endometrial epithelial cells in vitro. Biol Reprod 57: 936-942.
18. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, et al. (2006) The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7: 3.
19. Fleige S, Walf V, Huch S, Prgomet C, Sehm J, et al. (2006) Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR. Biotechnol Lett 28: 1601-1613.
20. Matsuzaki S, Jardon K, Maleysson E, D'Arpiany F, Canis M, et al. (2012) Impact of intraperitoneal pressure of a CO2 pneumoperitoneum on the surgical peritoneal environment. Hum Reprod 27: 1613-1623.
21. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, et al. (1999) Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 274: 13066-13076.
22. Yu Q, Stamenkovic I, (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 14: 163-176.
23. Sternlicht MD, Werb Z, (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516.
24. Björklund M, Koivunen E, (2005) Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 1755: 37-69.
25. Dufour A, Sampson NS, Zucker S, Cao J, (2008) Role of the hemopexin domain of matrix metalloproteinases in cell migration. J Cell Physiol 217: 643-651.
26. Dufour A, Zucker S, Sampson NS, Kuscu C, Cao J, (2010) Role of matrix metalloproteinase-9 dimers in cell migration: design of inhibitory peptides. J Biol Chem 285: 35944-35956.
27. Gaide Chevronnay HP, Selvais C, Emonard H, Galant C, Marbaix E, et al. (2012) Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration. Biochim Biophys Acta 1824: 146-156.
28. Collette T, Bellehumeur C, Kats R, Maheux R, Mailloux J, et al. (2004) Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9. Hum Reprod 19: 1257-1264.
29. Hull ML, Escareno CR, Godsland JM, Doig JR, Johnson CM, et al. (2008) Endometrial-peritoneal interactions during endometriotic lesion establishment. Am J Pathol 173: 700-715.
30. Wang Y, Hanifi-Moghaddam P, Hanekamp EE, Kloosterboer HJ, Franken P, et al. (2009) Progesterone inhibition of Wnt/beta-catenin signaling in normal endometrium and endometrial cancer. Clin Cancer Res 15: 5784-5793.
31. Burney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, et al. (2007) Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 148: 3814-3826.
32. Velarde MC, Aghajanova L, Nezhat CR, Giudice LC, (2009) Increased mitogen-activated protein kinase kinase/extracellularly regulated kinase activity in human endometrial stromal fibroblasts of women with endometriosis reduces 3′,5′-cyclic adenosine 5′-monophosphate inhibition of cyclin D1. Endocrinology 150: 4701-4712.
33. Aghajanova L, Horcajadas JA, Weeks JL, Esteban FJ, Nezhat CN, et al. (2010) The protein kinase A pathway-regulated transcriptome of endometrial stromal fibroblasts reveals compromised differentiation and persistent proliferative potential in endometriosis. Endocrinology 151: 1341-1355.
34. Borghese B, Mondon F, Noël JC, Fayt I, Mignot TM, et al. (2008) Gene expression profile for ectopic versus eutopic endometrium provides new insights into endometriosis oncogenic potential. Mol Endocrinol 22: 2557-2562.
35. Gaetje R, Kotzian S, Herrmann G, Baumann R, Starzinski-Powitz A, (1995) Invasiveness of endometriotic cells in vitro. Lancet 346: 1463-1464.
36. Zeitvogel A, Baumann R, Starzinski-Powitz A, (2001) Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model. Am J Pathol 159: 1839-1852.
37. Han SJ, Hawkins SM, Begum K, Jung SY, Kovanci E, et al. (2012) A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis. Nat Med 8: 1102-1111.
38. Kyama CM, Overbergh L, Debrock S, Valckx D, Vander Perre S, et al. (2006) Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosis. Fertil Steril 85: 1667-1675.